Park Avenue Securities LLC Annexon, Inc. Transaction History
Park Avenue Securities LLC
- $10.9 Billion
- Q2 2025
A detailed history of Park Avenue Securities LLC transactions in Annexon, Inc. stock. As of the latest transaction made, Park Avenue Securities LLC holds 113,068 shares of ANNX stock, worth $264,579. This represents 0.0% of its overall portfolio holdings.
Number of Shares
113,068
Previous 83,068
36.11%
Holding current value
$264,579
Previous $160,000
69.38%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ANNX
# of Institutions
154Shares Held
97MCall Options Held
36.9KPut Options Held
83K-
Satter Management Co., L.P.7.41MShares$17.3 Million71.99% of portfolio
-
Bvf Inc San Francisco, CA7MShares$16.4 Million0.59% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$15.4 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.3MShares$14.7 Million1.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.38MShares$12.6 Million0.0% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $111M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...